Issue 71, 2018

Synthesis and anti-glioblastoma effects of artemisinin-isothiocyanate derivatives

Abstract

A series of novel artemisinin (ART) derivatives containing an isothiocyanate (ITC) group were synthesized. All the compounds showed more potent anti-tumor effects than those of parent dihydroartemisinin (DHA) towards glioblastoma multiforme U87 in vitro. Among them, 5b had the strongest cytotoxic activity which exerted its effects in a concentration-dependent but not time-dependent manner (IC50 7.41 μM for 24 h, 7.35 μM for 72 h). Pyknosis was observed in 5b-treated U87 cells. Multiple intrinsic apoptotic pathways were induced by 5b including the upregulation of caspase 9, the release of cytochrome c, an increase of the proapoptotic protein Bax, a decrease of the anti-apoptotic protein Bcl 2, and the activation of execution pathways by the upregulation of caspase 3. In addition to apoptosis, an autophagic mechanism was also involved in 5b-induced cytotoxicity to human GBM U87 cells by upregulating the expression of LC3-II and downregulating p62. Furthermore, 5b also significantly attenuated the migration of U87 cells. Therefore, our results suggest that 5b may be a promising molecule for the further development of a novel drug for the treatment of glioblastoma.

Graphical abstract: Synthesis and anti-glioblastoma effects of artemisinin-isothiocyanate derivatives

Supplementary files

Article information

Article type
Paper
Submitted
02 Oct 2018
Accepted
19 Nov 2018
First published
07 Dec 2018
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2018,8, 40974-40983

Synthesis and anti-glioblastoma effects of artemisinin-isothiocyanate derivatives

C. M. Nyein, X. Zhong, J. Lu, H. Luo, J. Wang, S. Rapposelli, M. Li, Y. Ou-yang, R. Pi and X. He, RSC Adv., 2018, 8, 40974 DOI: 10.1039/C8RA08162J

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements